What is REGICOR?

REGICOR began with the Girona Heart Registry (Registre GIroní del COR) in 1978 and now brings together more than 50 researchers from two Barcelona research groups, EGEC and CARIN, of the Hospital del Mar Medical Research Institute (IMIM), from the Cardiology Services unit at Josep Trueta Hospital and the Primary Care Research Unit in Girona. The research focus is the population distribution of ischemic heart disease and associated risk factors, and improved prevention tools and strategies.



The REGICOR mission is to contribute to the available knowledge about the magnitude and causes of cardiovascular diseases. Researchers study the influence of molecular, cellular, and environmental mechanisms, with an emphasis on nutrition, physical activity, and obesity; the development of coronary disease; and the best prevention strategies at population scale. The final objective is to contribute to a significant reduction in the burden of these diseases. REGICOR also has a mission to prepare new researchers in this knowledge area.


The disease burden of ischemic heart diseases is reduced throughout western society by the collaborative and multidisciplinary efforts of an expert research community. Widespread knowledge of the protective factors discovered in South Europe and of the molecular end cellular mechanisms of disease contributes to coordinated efforts that continuously improve the accurate estimation of cardiovascular risk in any population and the implementation of optimal strategies of primary prevention.

Research lines

Cardiovascular genetics

Cardiovascular Genetics

In 1995, the REGICOR study began a new line of genetics research.

Cardiovascular risk functions

Cardiovascular Risk Functions

The equations to predict cardiovascular risk developed in Framingham [1] have been very useful decision-making tools in clinical practice to prevent and control cardiovascular risk factors.

Classic and emerging cardiovascular risk factors

Classic and Emerging Cardiovascular Risk Factors

In addition to determining the incidence, mortality, and morbidity associated with acute myocardial infarction (AMI), REGICOR has established the prevalence of cardiovascular risk factors in the study area and the level of control that has been achieved.

Cardiovascular risk self-screening system

Cardiovascular Risk Self-Screening System: The ACRISC Study (Auto-Cribatge del RISC cardiovascular)

Cardiovascular diseases are the leading cause of mortality in the developed world.

Nutrition studies

Nutrition Studies

The Mediterranean diet, our traditional food heritage, has healthy effects on morbidity and mortality related to cardiovascular diseases that have been widely described and scientifically proven.

Register of acute myocardial infarction patients

Register of Acute Myocardial Infarction Patients

The estimation of myocardial infarction incidence, mortality and survival rates requires access to population registers with a standardized methodology and the following characteristics: First, the study population must be clearly defined and stable over time, making it possible to compare epidemiologic indicators.


News and publications


Investigadores de Sant Pau y del IMIM descubren un nuevo biomarcador, el receptor sLRP1, que predice con mucha antelación el riesgo de desarrollar enfermedad cardiovascular en personas que actualmente no presentan ningún síntoma

Por cada incremento en una unidad del sLRP1 el riesgo de presentar enfermedad cardiovascular aumenta un 40% Las enfermedades cardiovasculares continúan siendo la principal causa de muerte en España. Además, se estima que cada año unas 125.000 personas presentan un infarto agudo de miocardio. Por este motivo, los investigadores están trabajando para identificar algunos parámetros…

Read more